- Home
- MBX vs MLP Comparison
MBX vs MLP Comparison
Compare MBX & MLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBX
- MLP
- Stock Information
- Founded
- MBX 2018
- MLP 1909
- Country
- MBX United States
- MLP United States
- Employees
- MBX N/A
- MLP N/A
- Industry
- MBX
- MLP Real Estate
- Sector
- MBX
- MLP Finance
- Exchange
- MBX NYSE
- MLP Nasdaq
- Market Cap
- MBX 381.4M
- MLP 344.7M
- IPO Year
- MBX 2024
- MLP 1972
- Fundamental
- Price
- MBX $13.29
- MLP $17.37
- Analyst Decision
- MBX Strong Buy
- MLP
- Analyst Count
- MBX 5
- MLP 0
- Target Price
- MBX $37.40
- MLP N/A
- AVG Volume (30 Days)
- MBX 365.8K
- MLP 22.0K
- Earning Date
- MBX 08-16-2025
- MLP 08-18-2025
- Dividend Yield
- MBX N/A
- MLP N/A
- EPS Growth
- MBX N/A
- MLP N/A
- EPS
- MBX N/A
- MLP N/A
- Revenue
- MBX N/A
- MLP $14,886,000.00
- Revenue This Year
- MBX N/A
- MLP N/A
- Revenue Next Year
- MBX N/A
- MLP N/A
- P/E Ratio
- MBX N/A
- MLP N/A
- Revenue Growth
- MBX N/A
- MLP 57.13
- 52 Week Low
- MBX $4.81
- MLP $14.05
- 52 Week High
- MBX $27.50
- MLP $26.46
- Technical
- Relative Strength Index (RSI)
- MBX N/A
- MLP 48.98
- Support Level
- MBX N/A
- MLP $17.72
- Resistance Level
- MBX N/A
- MLP $18.58
- Average True Range (ATR)
- MBX 0.00
- MLP 0.77
- MACD
- MBX 0.00
- MLP -0.08
- Stochastic Oscillator
- MBX 0.00
- MLP 35.80
About MBX MBX BIOSCIENCES INC
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.
About MLP Maui Land & Pineapple Company Inc.
Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales which includes land planning and entitlement, development, and sales activities; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.